Homepage

AptarGroup, Inc.

ATR NYSE Categories PDF
Healthcare · Medical - Instruments & Supplies
Crystal Lake, IL 60014, United States IPO 1993 aptar.com Updated Jun 27, 10:02am
Price
$125.98
Market Cap
$8.0B
Employees
13,000
Beta
0.40
Avg Volume
505,819
CEO
Stephan Tanda
Business Description

AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.

Business History
Price Overview
Last updated: Jun 27, 2026 10:02am (just now)
$125.98
-0.45 (-0.36%)
Day Range
$125.36 – $127.12
52-Week Range
$103.23 – $164.28
50-Day MA
$119.64
200-Day MA
$125.69
Volume
316,066.00
Analyst Price Targets
Low $156.00
Consensus $188.00
High $220.00
(11 analysts)
Share Structure
Outstanding 63,820,316.00
Float 63,194,877.00
Free Float 99.0%
High free float — 99.0% of shares trade freely, ~1% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Last updated: Jun 27, 2026 10:02am (just now)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Last updated: Jun 21, 2026 6:54pm (5d ago)
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
API
Stock Price / EPS (Diluted)
20.87
Stock Price: $125.98
EPS (Diluted): 5.97
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
3.01
Stock Price: $125.98
Total Equity: $2.67B
Shares: 66,724,999
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
11.05
Market Cap: $8.04B
Total Debt: $1.48B
Cash: $402.42M
EBITDA: $831.48M
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$9.1B
Market Cap: $8.04B
Total Debt: $1.48B
Cash: $402.42M
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
29.6%
Gross Profit: $1.12B
Revenue: $3.78B
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
13.6%
Operating Income: $512.34M
Revenue: $3.78B
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
10.4%
Net Income: $392.79M
Revenue: $3.78B
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
14.3%
Net Income: $392.79M
Total Equity: $2.67B
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
9.6%
Operating Income: $512.34M
Tax Rate: 20.1%
Equity: $2.67B
Total Debt: $1.48B
Cash: $402.42M
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
1.62
Current Assets: $1.89B
Current Liabilities: $1.17B
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.56
Short-Term Debt: $343.53M
Long-Term Debt: $1.14B
Total Debt: $1.48B
Total Equity: $2.67B
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$56.61
Revenue: $3.78B
Shares: 66,724,999
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$39.99
Total Equity: $2.67B
Shares: 66,724,999
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$4.49
Operating CF: $570.00M
CapEx: -$270.42M
Shares: 66,724,999
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
1.5%
Last Dividend: N/A
Stock Price: $125.98
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
Dividends Paid: N/A
Net Income: $392.79M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares ATR against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 21, 2026 6:54pm (5d ago)
Metric 2021 2022 2023 2024 2025
Revenue $3.2B $3.3B $3.5B $3.6B $3.8B
Cost of Revenue $2.1B $2.2B $2.2B $2.2B $2.7B
Gross Profit $1.2B $1.2B $1.3B $1.4B $1.1B
Operating Expenses $809.3M $784.6M $859.4M $859.0M $605.0M
Operating Income $347.3M $379.3M $404.0M $496.5M $512.3M
Net Income $244.1M $239.3M $284.5M $374.5M $392.8M
EBITDA $586.8M $609.4M $663.8M $777.4M $831.5M
EPS $3.72 $3.66 $4.34 $5.65 $5.97
EPS (Diluted)
Balance Sheet (Annual)
Last updated: Jun 21, 2026 6:54pm (5d ago)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $122.9M $141.7M $223.6M $223.8M $402.4M
Total Current Assets $1.4B $1.4B $1.5B $1.5B $1.9B
Total Assets $4.1B $4.2B $4.5B $4.4B $5.3B
Current Liabilities $982.5M $917.2M $1.3B $1.1B $1.2B
Long-Term Debt $907.0M $1.1B $681.2M $688.1M $1.1B
Total Liabilities $2.2B $2.1B $2.1B $1.9B $2.5B
Total Equity $2.0B $2.1B $2.3B $2.5B $2.7B
Retained Earnings $1.8B $1.9B $2.1B $2.4B $2.6B
Cash Flow (Annual)
Last updated: Jun 21, 2026 6:54pm (5d ago)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $363.4M $478.6M $575.2M $643.4M $570.0M
Capital Expenditure -$307.9M -$315.6M -$318.4M -$294.2M -$270.4M
Free Cash Flow $55.5M $163.0M $256.8M $349.2M $299.6M
Acquisitions (net) -$148.4M -$4.1M -$16.6M $0 -$55.9M
Debt Repayment
Dividends Paid
Stock Buybacks -$78.1M -$92.1M -$47.6M -$68.6M -$365.0M
Net Change in Cash -$182.0M $19.8M $81.4M $201,000 $178.1M
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 10:02am (just now)
Metric 2025 2026 2027 2028
Revenue $3.7B
$3.7B – $3.7B
$4.0B
$3.9B – $4.0B
$4.2B
$4.1B – $4.2B
$4.4B
$4.4B – $4.4B
EBITDA $732.5M
$730.5M – $734.5M
$791.0M
$783.0M – $799.0M
$827.8M
$821.8M – $831.8M
$877.1M
$873.4M – $880.8M
Net Income $381.1M
$379.1M – $383.1M
$367.4M
$354.9M – $380.0M
$402.1M
$393.9M – $446.5M
$472.1M
$448.7M – $495.5M
EPS
Growth Trends (YoY %)
Last updated: Jun 21, 2026 6:54pm (5d ago)
Metric 2022 2023 2024 2025
Revenue Growth +2.9% +5.0% +2.7% +5.4%
Gross Profit Growth +0.6% +8.6% +7.3% -17.6%
Operating Income Growth +9.2% +6.5% +22.9% +3.2%
Net Income Growth -2.0% +18.9% +31.7% +4.9%
EBITDA Growth +3.9% +8.9% +17.1% +6.9%
Insider Trading (Recent)
Type codes PPurchase SSale AAward / grant MOption exercise FIn-kind (tax) CConversion GGift DReturn to issuer
All SEC Form 4 codes
Open market
P Purchase
Open-market or private purchase of shares.
S Sale
Open-market or private sale of shares.
Compensation (Rule 16b-3)
A Award / grant
Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
D Return to issuer
Securities disposed back to the company under Rule 16b-3.
F In-kind (tax)
Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
I Discretionary
Discretionary transaction under an employee plan — Rule 16b-3(f).
M Option exercise
Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
C Conversion
Conversion of a derivative security into the underlying shares.
E Short expiration
Expiration of a short derivative position.
H Long expiration
Expiration or cancellation of a long derivative position with value received.
O OTM exercise
Exercise of an out-of-the-money derivative.
X ITM exercise
Exercise of an in-the-money or at-the-money derivative.
Other exempt
G Gift
Bona fide gift of securities.
L Small acquisition
Small acquisition under Rule 16a-6.
W Inheritance
Acquisition or disposition by will or the laws of descent.
Z Voting trust
Deposit into or withdrawal from a voting trust.
Other
J Other
Other acquisition or disposition (explained in a Form 4 footnote).
K Equity swap
Transaction in an equity swap or similar instrument.
U Tender / buyout
Disposition via tender of shares in a change-of-control transaction.

Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.

Date Insider Type Shares Price Value
2026-06-15 Gandhi Aditya A-Award 2,664.00 $0.00 $0
2026-06-09 Prieur Marc S-Sale 4,553.00 $115.53 $526,007
2026-06-09 Prieur Marc S-Sale 447.00 $116.08 $51,887
2026-06-08 Gandhi Aditya 0.00 $0.00 $0
2026-06-04 Vinczeller Shiela S-Sale 2,957.00 $112.36 $332,240
2026-06-04 Vinczeller Shiela S-Sale 385.00 $113.52 $43,706
2026-06-04 Vinczeller Shiela S-Sale 213.00 $114.53 $24,395
2026-05-26 Gong Xiangwei S-Sale 4,200.00 $116.13 $487,765
2026-05-21 Tlili Hedi F-InKind 688.00 $116.50 $80,152
2026-05-07 Hudson Irene Elizabeth M-Exempt 842.00 $111.38 $93,782
2026-05-07 Hudson Irene Elizabeth S-Sale 422.00 $123.38 $52,067
2026-05-07 Hudson Irene Elizabeth S-Sale 842.00 $123.45 $103,946
2026-05-07 Hudson Irene Elizabeth M-Exempt 842.00 $111.38 $93,782
2026-05-06 Marey-Semper Isabel A-Award 1,326.00 $0.00 $0
2026-05-06 Kampouri Monnas Giovanna A-Award 1,326.00 $0.00 $0
2026-05-06 Owens B Craig A-Award 1,326.00 $0.00 $0
2026-05-06 Glickman Sarah JS A-Award 1,326.00 $0.00 $0
2026-05-06 FOTIADES GEORGE L A-Award 1,326.00 $0.00 $0
2026-05-06 Trerotola Matthew L. A-Award 1,326.00 $0.00 $0
2026-05-06 Wunderlich Ralf K. A-Award 1,326.00 $0.00 $0
Dividend History (Last 20)
Last updated: Jun 21, 2026 6:54pm (5d ago)
Date Dividend Declaration Record Payment
2026-05-06 $0.48 2026-04-23 2026-05-06 2026-05-27
2026-02-04 $0.48 2026-01-22 2026-02-04 2026-02-25
2025-10-23 $0.48 2025-09-08 2025-10-23 2025-11-13
2025-07-24 $0.45 2025-07-10 2025-07-24 2025-08-14
2025-05-01 $0.45 2025-04-17 2025-05-01 2025-05-22
2025-02-05 $0.45 2025-01-23 2025-02-05 2025-02-26
2024-10-24 $0.45 2024-10-10 2024-10-24 2024-11-14
2024-07-25 $0.45 2024-07-11 2024-07-25 2024-08-15
2024-04-24 $0.41 2024-04-11 2024-04-25 2024-05-16
2024-01-31 $0.41 2024-01-18 2024-02-01 2024-02-22
2023-10-25 $0.41 2023-10-12 2023-10-26 2023-11-16
2023-07-26 $0.41 2023-07-13 2023-07-27 2023-08-17
2023-05-03 $0.38 2023-04-20 2023-05-04 2023-05-25
2023-02-01 $0.38 2023-01-19 2023-02-02 2023-02-23
2022-10-25 $0.38 2022-10-13 2022-10-26 2022-11-16
2022-07-26 $0.38 2022-07-13 2022-07-27 2022-08-17
2022-04-26 $0.38 2022-04-14 2022-04-27 2022-05-18
2022-02-02 $0.38 2022-01-20 2022-02-03 2022-02-23
2021-10-26 $0.38 2021-10-14 2021-10-27 2021-11-17
2021-08-03 $0.38 2021-07-22 2021-08-04 2021-08-25
Narrative Economics
The story the market is telling about this stock — the intangible X-factor (founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for ATR — it's generated by the pipeline (market-narrative step).
Community AI Feedback
No community reviews yet for ATR. Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30